Tenet Healthcare Corporation New financials
$257.60−0.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.63B | $5.78B | $5.35B | $5.35B | $5.27B | $5.22B | $4.89B | $5.19B | $5.11B | $5.37B | $5.38B | $5.07B |
| Gross profit | $5.63B | $5.78B | $5.35B | $5.35B | $5.27B | $5.22B | $4.89B | $5.19B | $5.11B | $5.37B | $5.38B | $5.07B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $1.40B | $1.24B | $590.0M | $889.0M | $800.0M | $865.0M | -$2.35B | $1.09B | $642.0M | $726.0M | $651.0M | $518.0M |
| Net income | $826.0M | $702.0M | $371.0M | $342.0M | $288.0M | $406.0M | $318.0M | $472.0M | $259.0M | $2.15B | $244.0M | $101.0M |
| Net margin | 14.7% | 12.1% | 6.9% | 6.4% | 5.5% | 7.8% | 6.5% | 9.1% | 5.1% | 40.1% | 4.5% | 2.0% |
| Diluted EPS | $9.84 | $8.01 | $4.22 | $3.86 | $3.14 | $4.27 | $3.32 | $4.89 | $2.64 | $21.38 | $2.35 | $0.94 |
| EBITDA | $1.24B | $1.52B | $915.0M | $1.12B | $1.06B | $1.11B | -$2.12B | $1.33B | $884.0M | $965.0M | $723.0M | $803.0M |
| Operating cash flow | $585.0M | $1.64B | $731.0M | $1.06B | $936.0M | $815.0M | -$331.0M | $1.04B | $747.0M | $586.0M | $824.0M | $503.0M |
| Free cash flow | $417.0M | $1.46B | $367.0M | $778.0M | $743.0M | $642.0M | -$661.0M | $829.0M | $602.0M | $346.0M | $616.0M | $327.0M |
| Diluted shares | 84.0M | 87.6M | 87.9M | 88.6M | 91.8M | 95.0M | 95.8M | 96.7M | 98.4M | 100.6M | 104.0M | 104.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.17B | $2.97B | $2.88B | $2.98B | $2.63B | $3.00B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $13.36B | $13.46B | $13.25B | $13.44B | $13.32B | $13.42B |
| Total assets | $30.68B | $31.20B | $29.68B | $29.42B | $28.70B | $29.24B |
| Total liabilities | $21.98B | $22.35B | $20.70B | $20.72B | $20.40B | $20.58B |
| Shareholders' equity | $6.56B | $6.71B | $6.02B | $5.78B | $5.48B | $5.88B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology